Should You Hold Viking Therapeutics in Your Portfolio?
Viking Therapeutics VKTX, a clinical-stage company focused on developing novel therapeutics for metabolic and endocrine disorders, has been in the news, owing to updates from its obesity program. The company, with a market cap of about $8 billion, is …